PRTA
NASDAQ · Biotechnology
Prothena Corp Plc
$9.43
+0.12 (+1.29%)
Open$9.17
Previous Close$9.31
Day High$9.50
Day Low$9.16
52W High$16.67
52W Low$4.32
Volume—
Avg Volume374.9K
Market Cap459.71M
P/E Ratio—
EPS$-5.21
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+43.4% upside
Current
$9.43
$9.43
Target
$13.52
$13.52
$9.22
$13.52 avg
$14.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 133.27M | 152.02M | 162.70M |
| Net Income | -120,605,745 | -123,811,076 | -26,550,677 |
| Profit Margin | -90.5% | -86.0% | -16.3% |
| EBITDA | -151,708,942 | -164,393,173 | -39,466,979 |
| Free Cash Flow | — | — | -19,760,246 |
| Rev Growth | -12.3% | -12.3% | +13.5% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |